title: [Clinical observation on scalp point injection to improve the cerebral microcirculation for children of early cerebral palsy].
abstract: OBJECTIVE
  To explore an effective therapy for children of early cerebral palsy.
  
  
  METHODS
  One hundred and twenty cases were randomly divided into an acupoint injection group and a medication group, 60 cases in each group. The acupoint injection group was treated with scalp point injection of 0.5-1 mL brain protein hydrolysate into each point, Baihui (GV 20), Fengchi (GB 20) and motor area etc. were selected; the medication group was treated with 10 mL brain protein hydrolysate by intravenous drip. The therapeutic effects in the two groups were observed, and the changes of cerebral blood flow were compared before and after treatment.
  
  
  RESULTS
  The total effective rate of 91.4% in the acupoint injection group was superior to that of 73.7% in the medication group (P<0.05), the acupoint injection group could significantly improve the systolic peak velocity (Vs), end diastolic velocity (Ved) and mean velocity (Vm) of middle cerebral artery (MCA) and anterior cerebral artery (ACA), and decrease the vascular resistance index (RI) (all P<0.05), and the improvement degree was superior to the medication group (all P<0.05).
  
  
  CONCLUSIONS
  Scalp point injection therapy can significantly improve the cerebral microcirculation of patients, and has a good therapeutic effect for early cerebral palsy.
authors.affiliation: Acupuncture Department, Weifang TCM Hospital of Shandong Province, Weifang 261041, China. susu336800@126.com
authors.forename: Xiu-zhen
authors.initials: XZ
authors.lastname: Su
authors.forename: Yong-gang
authors.initials: YG
authors.lastname: Zhao
mesh_terms: D015669:Acupuncture Points; D002547:Cerebral Palsy / Q000188:drug therapy* / Q000503:physiopathology; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002648:Child; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007267:Injections; D008297:Male; D011492:Protein Hydrolysates / Q000627:therapeutic use*; D012535:Scalp / Q000098:blood supply / Q000187:drug effects* / Q000503:physiopathology
chemical_list: D004365:Drugs, Chinese Herbal; D011492:Protein Hydrolysates